Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetically relevant polymorphisms in Portugal.

E Oliveira1, S Marsh, D J van Booven

  • 1University of Porto, Institute of Pathology and Molecular Immunology, 4200-465 Porto, Portugal. eoliveira@ipatimup.pt

Pharmacogenomics
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-chromosomal STRs: Metapopulations and mutation rates.

Forensic science international. Genetics·2025
Same author

Elexacaftor/tezacaftor/ivacaftor, a game-changer in cystic fibrosis: The Portuguese experience.

Pulmonary pharmacology & therapeutics·2024
Same author

A dynamical measure of the black hole mass in a quasar 11 billion years ago.

Nature·2024
Same author

Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.

Cancer genetics·2023
Same author

Characterization of a DRC1 null variant associated with primary ciliary dyskinesia and female infertility.

Journal of assisted reproduction and genetics·2023
Same author

Spatio-temporal dynamics of phytoplankton community in a well-mixed temperate estuary (Sado Estuary, Portugal).

Scientific reports·2022
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

This study analyzed drug-metabolizing enzyme gene frequencies in Portugal, finding patterns similar to other Europeans but with some African influence. This data is crucial for personalized medicine and cancer prevention strategies in Portugal.

Area of Science:

  • Pharmacogenomics
  • Population Genetics
  • Drug Metabolism

Background:

  • Drug development often relies on European reference populations, overlooking population-specific genetic variations.
  • Clinically relevant DNA polymorphisms exhibit varying allele frequencies across different ethnic groups.
  • Understanding these frequencies is vital for tailoring therapeutic strategies and national health policies.

Purpose of the Study:

  • To determine the allele frequencies of key drug-metabolizing enzymes in the Portuguese population.
  • To assess the distribution of pharmacogenetically relevant genetic variations in Portugal.
  • To provide baseline data for personalized medicine and public health planning.

Main Methods:

  • Employed Polymerase Chain Reaction (PCR) and Pyrosequencing techniques.

Related Experiment Videos

  • Assessed 15 key polymorphisms in genes involved in drug metabolism (Phases I, II, III), DNA repair, and intracellular metabolism.
  • Analyzed samples from 135 healthy Portuguese individuals.

    • Main Results:

    • Derived allele frequencies for numerous cytochrome P450 (CYP), glutathione S-transferase (GST), UDP-glucuronosyltransferase (UGT), and ATP-binding cassette (ABC) genes.
    • Observed frequencies generally aligned with other European populations, with notable exceptions.
    • Identified evidence suggesting some degree of African genetic influence on these polymorphisms.

    Conclusions:

    • The genetic profiles of drug-metabolizing enzymes in Portugal largely resemble those of other European populations.
    • Some observed allele frequencies indicate a potential African genetic contribution.
    • This comprehensive pharmacogenetic data serves as a crucial baseline for guiding drug treatment policies and cancer prevention in Portugal.